TSPO and myocardial infarction: We previously reported the development of [18F]LW223, a quinoline-2-carboxamide bearing an R-configured side chain, which binds TSPO independently of the rs6971 human polymorphism and enables quantification of macrophage-driven inflammation in the course of myocardial infarction.